BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12774009)

  • 1. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature.
    Mommeja-Marin H; Mondou E; Blum MR; Rousseau F
    Hepatology; 2003 Jun; 37(6):1309-19. PubMed ID: 12774009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy.
    Bourne EJ; Dienstag JL; Lopez VA; Sander TJ; Longlet JM; Hall JG; Kwiatkowski RW; Wright T; Lai CL; Condreay LD
    J Viral Hepat; 2007 Jan; 14(1):55-63. PubMed ID: 17212645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations between preS1-antigen, HBV-DNA and HBV serum markers in patients with chronic hepatitis B].
    Zhou H; Jiang CW; Qian JL; Li SJ; Liang JL; Chen XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1184-6. PubMed ID: 18676258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between liver pathological characteristics and serum HBeAg and HBV DNA in 1057 patients with chronic hepatitis B].
    Fan HM; Zhang CL; Ying RS; Chen ZM; Feng QC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):130-2. PubMed ID: 18574537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients.
    Lian M; Zhou X; Wei L; Qiu S; Zhou T; Li L; Gu X; Luo M; Zheng X
    Virol J; 2007 Sep; 4():93. PubMed ID: 17892580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.
    Bayram A; Erkilic S; Ozkur A; Bayram M; Sari I
    J Clin Pathol; 2008 Mar; 61(3):338-42. PubMed ID: 17693576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
    van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
    J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome in children with chronic hepatitis B: a 24-year observation period.
    Iorio R; Giannattasio A; Cirillo F; D' Alessandro L; Vegnente A
    Clin Infect Dis; 2007 Oct; 45(8):943-9. PubMed ID: 17879906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
    Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
    J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
    Evans A; Riva A; Cooksley H; Phillips S; Puranik S; Nathwani A; Brett S; Chokshi S; Naoumov NV
    Hepatology; 2008 Sep; 48(3):759-69. PubMed ID: 18697210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the correlation between PreS1-Ag, PreS2-Ag, HBeAg and HBV DNA in the serum of chronic hepatitis B patients].
    Dou YL; Han JH; Li YZ; DI Q; Ni AP
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1984-6. PubMed ID: 17923040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating hepatitis B virus nucleic acids in chronic infection : representation of differently polyadenylated viral transcripts during progression to nonreplicative stages.
    Su Q; Wang SF; Chang TE; Breitkreutz R; Hennig H; Takegoshi K; Edler L; Schröder CH
    Clin Cancer Res; 2001 Jul; 7(7):2005-15. PubMed ID: 11448918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship among pathological changes in Liver tissues and level of serum HBV DNA, HBeAg and ALT of 194 patients with chronic hepatitis B].
    Zhao DY; Qin YQ; Tang XM; Liu GZ; Zheng W; Nong HR; Song JJ; Xie QY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):35-7. PubMed ID: 17429530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B.
    Yuen MF; Ng IO; Fan ST; Yuan HJ; Wong DK; Yuen JC; Sum SS; Chan AO; Lai CL
    Am J Gastroenterol; 2004 Oct; 99(10):2032-7. PubMed ID: 15447768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.